Drug Type CAR-T |
Synonyms ARD 102, ARD102 |
Target |
Action inhibitors |
Mechanism CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Discovery | China | 16 Apr 2023 |